SCHEMBL2199067

SCHEMBL2199067

CCOS(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA9 Q16790 1/20 0.52
HTR6 P50406 2/20 0.47
F2 P00734 3/20 0.45
PRSS1 P07477 3/20 0.45
PRSS2 P07478 3/20 0.45
PRSS3 P35030 3/20 0.45
HCRTR1 O43613 1/20 0.43
CDC25B P30305 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
NR1D1 P20393 1/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8332473 0.98 CA1 (0.50) CA1CA2CA9HTR6F2
SCHEMBL2761905 0.98 CA1 (0.50) CA1CA2CA9HTR6F2
Formaldehyde SCHEMBL18139835 0.95 CA1 (0.47) CA1CA2CA9HTR6F2
SCHEMBL9152668 0.89 TTR (0.41) CA1CA2CA9MEN1KMT2A
SCHEMBL2197579 0.86 CA1 (0.49) CA1CA2CA9HTR6F2
SCHEMBL6115042 0.85 CA1 (0.55) CA1CA2CA9HTR6F2
SCHEMBL29409565 0.85 CA1 (0.55) CA1CA2CA9HTR6F2
SCHEMBL9576084 0.85 CA1 (0.55) CA1CA2CA9HTR6F2
SCHEMBL6755471 0.85 CA1 (0.47) CA1CA2CA9HTR6F2
SCHEMBL5357414 0.85 CA1 (0.47) CA1CA2CA9HTR6F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107151245-A A kind of preparation method of levo-praziquantel 苏州同力生物医药有限公司 2017-09-12 CN claimed
US-20100048713-A1 COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER AARHUS UNIVERSITET (DK) 2010-02-25 US claimed
US-7572847-B2 Aromatic polycarbonate resin composition and production method thereof ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-08-11 US claimed
EP-1976495-A2 COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER Aarhus Universitet (DK) 2008-10-08 EP claimed
WO-2007076875-A2 COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER AARHUS UNIVERSITET (DK) 2007-07-12 WO claimed
US-6326122-B1 HEAT SENSITIVE ELEMENTS MITSUBISHI CHEMICAL CORPORATION (JP) 2001-12-04 US claimed
EP-3511375-B1 POLYCARBONATE RESIN COMPOSITION MITSUBISHI CHEM CORP (JP) 2026-04-08 EP disclosed
EP-4559963-A2 POLYCARBONATE RESIN COMPOSITION Mitsubishi Chemical Corporation (JP) 2025-05-28 EP disclosed
CN-113784786-B Deodorant-containing processing liquid and method for producing deodorant product using same 东亚合成株式会社 2023-07-21 CN disclosed
CN-111324008-B Photosensitive composition and application thereof 乐凯华光印刷科技有限公司 2023-04-14 CN disclosed
US-11603467-B2 Polycarbonate resin composition MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) 2023-03-14 US disclosed
US-20220325099-A1 POLYCARBONATE RESIN COMPOSITION MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) 2022-10-13 US disclosed
CN-109689784-B Polycarbonate resin composition 三菱工程塑料株式会社 2022-04-29 CN disclosed
EP-0291588-B1 SIZING AGENT KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) 1991-09-04 EP disclosed
EP-0224976-B1 METHOD OF SIZING PAPER KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) 1989-10-18 EP disclosed
CN-87104680-A SIZING AGENT 1988-12-14 CN disclosed
EP-0291588-A1 Sizing agent KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) 1988-11-23 EP disclosed
EP-0224976-A1 Method of sizing paper KABUSHIKI KAISHA CHIYODA KAGAKU KENKYUSHO (JP) 1987-06-10 EP disclosed
US-4271325-A DEHYDROHALOGENATION, STANNIC CHLORIDE CATALYST STAUFFER CHEMICAL COMPANY (US) 1981-06-02 US disclosed
US-3977828-A HYDROTROPIC AGENTS CIBA-GEIGY AG (CH) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048713-A1 COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER SLC6A4, SLC18A2, SLC6A3 CA1 2431/4885CA2 3922/4885CA9 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.